Express Scripts Turns To Compounding To Fight High-Priced Off-Patent Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmacy benefit manager's anti-Daraprim effort signals new direction in pricing battles, but the strategy can only be used in limited circumstances.